This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For 19 years, the Cardiometabolic Health Congress (CMHC) has worked towards a vision of a better future for clinicians, patients, and the entire health sector. This fall, we come together for the largest and most innovative cardiometabolic event in honor of the legacy of Dr. George L.
Concurrently, the CNS worked with informatics to optimize EHR systems and update the RiskFactor activation process for individualization.Results:EHR optimizations reduced missed documentation and improved rounding efficiency.
With his support, CMHC has championed a vision of a brighter future for clinicians, patients, and the entire healthcare sector. This October, we gather for the largest and most innovative cardiometabolic event, honoring Dr. Bakris’ profound impact on our community. Contact Data Megan Magana, Sr.
Patients flagged by the AI for low ejection fraction were twice as likely to experience MACE compared to those without a positive AI result. These patients also faced a 65% higher mortality rate, even after adjusting for traditional riskfactors. Nicholas S. Peters, Director of the Health Impact Lab at Imperial.
As Biosense Webster advances innovation for the treatment of AFib, we are thinking not only about new modalities of ablation, such as pulsed field ablation, but also how to make procedures safer, more effective and efficient. 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib.4 Circulation Research.
24 and how those may impact clinical practice and patientcare in this deep dive clinical trial session. ET Murphy Ballroom 4 ACC.24 24 planners note that attendees can gain insights from key clinical trials presented at ACC.24 More information: www.acc.org If you enjoy this content, please share it with a colleague
We need a comprehensive and innovative approach to cardiorenal metabolic management and risk reduction to address this challenge. One promising strategy is the formation of creative partnerships between patients and their healthcare teams. This ensures clear communication and identifies areas that need further explanation.
Some of the latest strategies include: Innovations in Thrombolysis and Clot Retrieval : Techniques such as tissue plasminogen activator (tPA) injections and mechanical thrombectomy are significantly improving recovery rates for ischemic stroke patients. www.adncoe.com
The Smidt Heart Institute recently received CAROL Act funding to study the connection between ventricular arrhythmias—abnormal heartbeats that start in the heart’s two lower chambers—and an elevated risk of sudden cardiac death in patients with mitral valve disease. Patients come to us from all over the U.S.
On World Heart Day, cardiologists can make a significant impact by: Spreading Awareness: They can educate the public about the riskfactors and warning signs of heart diseases. Encouraging Regular Check-ups: Cardiologists play a vital role in promoting preventive care.
Efficient diagnosis and therapy are key elements of addressing the growing demand for care. allows clinicians to focus on what truly matters providing exceptional patientcare. Global Burden of Cardiovascular Diseases and RiskFactors, 19902019: Update From the GBD 2019 Study. AltiX AI.i AltiX AI.i AltiX AI.i
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content